Minoxidil 2% for Eyebrow Enhancement
NCT01672307 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2013-06-19
Summary
The purpose of the study is to compare minoxidil 2% versus placebo in enhancement of eyebrows.
Conditions
- Hypotrichosis of Eyebrows
- Thinning Eyebrows
Interventions
- DRUG
-
Minoxidil lotion 2%
Minoxidil lotion 2% is applied twice daily to one eyebrow.
- DRUG
-
Placebo is applied twice daily to the other eyebrow.
Sponsors & Collaborators
-
Mae Fah Luang University Hospital
lead OTHER
Principal Investigators
-
Chuchai Tanglertsampan, MD · MFL University Hospital (Bangkok)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2012-11-30
- Completion
- 2013-03-31
Countries
- Thailand
Study Locations
More Related Trials
-
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
NCT07011485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
NCT01319370 ·Status: COMPLETED ·Phase: PHASE2
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
NCT00151515 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
NCT00958750 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
NCT02503137 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia
NCT01650272 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
NCT06924632 ·Status: COMPLETED ·Phase: PHASE3
-
Minoxidil for Treating White Hair: A Randomized Controlled Trial
NCT06813963 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
NCT05587257 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
NCT02154503 ·Status: UNKNOWN ·Phase: PHASE1
-
Minoxidil Response Testing in Males With Androgenetic Alopecia
NCT02198261 ·Status: COMPLETED
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
NCT02275351 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration
NCT04984707 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
NCT05888922 ·Status: RECRUITING ·Phase: PHASE3
-
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
NCT05989165 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
NCT05910450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
NCT01655108 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
NCT07273799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
NCT01904721 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
NCT05218642 ·Status: COMPLETED ·Phase: PHASE2
-
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
NCT05790941 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
NCT02676310 ·Status: TERMINATED ·Phase: PHASE1